In an early trial, patients received a single infusion of a CRISPR-based therapy to knock out the mutated gene responsible for their disease.
Breakthrough CRISPR Gene Therapy Could Be a ‘One and Done’ Injection
Posted in biotech/medical, innovation
Posted in biotech/medical, innovation
In an early trial, patients received a single infusion of a CRISPR-based therapy to knock out the mutated gene responsible for their disease.